Salmonella Conjugates CVD 1000: Study of Responses to Vaccination With Trivalent Invasive Salmonella Disease Vaccine
Condition: Risk Reduction Interventions: Biological: Trivalent Invasive Salmonella Disease Vaccine (6.25 µg); Biological: Trivalent Invasive Salmonella Disease Vaccine (12 µg); Biological: Trivalent Invasive Salmonella Disease Vaccine (25 µg); Biological: Trivalent Invasive Salmonella Disease Vaccine (highest, well-tolerate d dose among Cohorts A-C); Other: Placebo Sponsor: University of Maryland Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials